The evaluation of ectopic bone formation induced by delivery systems for bone morphogenetic protein-9 or its derived peptide

Tissue Engineering - Part A

Volumn 18, Issue 3-4, 2012, Pages 342-352

  Bergeron, Eric ^a   Leblanc, Elisabeth ^a   Drevelle, Olivier ^a   Giguère, Randy ^a   Beauvais, Sabrina ^a   Grenier, Guillaume ^a   Faucheux, Nathalie ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CHITOSAN; COLLAGEN; COMPUTERIZED TOMOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAMMALS; PEPTIDES;

BONE FORMATION; BONE STRUCTURE; C57BL/6 MICE; DELIVERY SYSTEMS; ECTOPIC BONES; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGICAL ANALYSIS; IN-VITRO; IN-VIVO; MC3T3-E1; MICRO-COMPUTERIZED TOMOGRAPHY; PREOSTEOBLASTS; RELEASE KINETICS;

BONE;

MUS;

BONE MORPHOGENETIC PROTEIN 9; PEPTIDE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; C57BL MOUSE; CHO CELL; CHORISTOMA; CRICETULUS; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METHODOLOGY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MUSCLE; PATHOLOGY; RADIOGRAPHY;

ANIMALS; CHO CELLS; CHORISTOMA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUSCLES; OSTEOGENESIS; PEPTIDES; X-RAY MICROTOMOGRAPHY;

EID: 84856281852     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0008     Document Type: Article

References (64)

1. Franceschi, R.T. The developmental control of osteoblastspecific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 10, 40, 1999.
2. Urist, M.R. Bone: Formation by autoinduction. Science 150, 893, 1965.
3. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2, 1, 2008.
4. Schmierer, B., and Hill, C.S. TGFb-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8, 970, 2007.
5. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
6. Matsubara, T., Kida, K., Yamaguchi, A., Hata, K., Ichida, F., Meguro, H., Aburatani, H., Nishimura, R., and Yoneda, T. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283, 29119, 2008.
7. Suttapreyasri, S., Koontongkaew, S., Phongdara, A., and Leggat, U. Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones. Int J Oral Maxillofac Surg 35, 444, 2006.
8. Burkus, J.K., Heim, S.E., Gornet, M.F., and Zdeblick, T.A. The effectiveness of rhBMP-2 in replacing autograft: An integrated analysis of three human spine studies. Orthopedics 27, 723, 2004.
9. Kang, Q., Sun, M.H., Cheng, H., Peng, Y., Montag, A.G., Deyrup, A.T., Jiang, W., Luu, H.H., Luo, J., Szatkowski, J.P., Vanichakarn, P., Park, J.Y., Li, Y., Haydon, R.C., and He, T.-C. Characterization of the distinct orthotopic boneforming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11, 1312, 2004.
10. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. Novel regulators of bone formation: Molecular clones and activities. Science 242, 1528, 1988.
11. Brown, M.A., Zhao, Q., Baker, K.A., Naik, C., Chen, C., Pukac, L., Singh, M., Tsareva, T., Parice, Y., Mahoney, A., Roschke, V., Sanyal, I., and Choe, S. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280, 25111, 2005.
12. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11, 605, 2003.
13. Keller, S., Nickel, J., Zhang, J.-L., Sebald, W., and Mueller, T.D. Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol 11, 481, 2004.
14. Kirsch, T., Sebald, W., and Dreyer, M.K. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol 7, 492, 2000.
15. Kirsch, T., Nickel, J., and Sebald, W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J 19, 3314, 2000.
16. Saremba, S., Nickel, J., Seher, A., Kotzsch, A., Sebald, W., and Mueller, T.D. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand. FEBS J 275, 172, 2008.
17. Thompson, T.B., Woodruff, T.K., and Jardetzky, T.S. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-b ligand:receptor interactions. EMBO J 22, 1555, 2003.
18. Bergeron, E., Marquis, M.E., Chretien, I., and Faucheux, N. Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres. J Mater Sci Mater Med 18, 255, 2007.
19. Chen, Y., and Webster, T.J. Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications. J Biomed Mater Res 91A, 296, 2009.
20. Duan, Z., Zheng, Q., Guo, X., Yuan, Q., and Chen, S. Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers. J Huazhong Univ Sci Technol Med Sci 27, 179, 2007.
21. Kirkwood, K., Rheude, B., Kim, Y.J., White, K., and Dee, K.C. In vitro mineralization studies with substrate-immobilized bone morphogenetic protein peptides. J Oral Implantol 29, 57, 2003.
22. Saito, A., Suzuki, Y., Ogata, S.-I., Ohtsuki, C., and Tanihara, M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 1651, 60, 2003.
23. Suzuki, Y., Tanihara, M., Suzuki, K., Saitou, A., Sufan, W., and Nishimura, Y. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J Biomed Mater Res 50, 405, 2000.
24. Bergeron, E., Senta, H., Mailloux, A., Park, H., Lord, E., and Faucheux, N. Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9. Tissue Eng Part A 15, 3341, 2009.
25. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z.P., Deng, J.M., Behringer, R.R., and de Crombrugghe, B. The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108, 17, 2002.
26. Poynton, A.R., and Lane, J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27, S40, 2002.
27. Seeherman, H., and Wozney, J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16, 329, 2005.
28. Biondi, M., Ungaro, F., Quaglia, F., and Netti, P.A. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 60, 229, 2008.
29. Senta, H., Park, H., Bergeron, E., Drevelle, O., Fong, D., Leblanc, E., Cabana, F., Roux, S., Grenier, G., and Faucheux, N. Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations. Cytokine Growth Factor Rev 20, 213, 2009.
30. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81, 2008.
31. Luginbuehl, V., Meinel, L., Merkle, H.P., and Gander, B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58, 197, 2004.
32. Rezwan, K., Chen, Q.Z., Blaker, J.J., and Boccaccini, A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27, 3413, 2006.
33. Olivier, V., Faucheux, N., and Hardouin, P. Biomaterial challenges and approaches to stem cell use in bone reconstructive surgery. Drug Discov Today 9, 803, 2004.
34. Kanakaris, N.K., Calori, G.M., Verdonk, R., Burssens, P., De Biase, P., Capanna, R., Vangosa, L.B., Cherubino, P., Baldo, F., Ristiniemi, J., Kontakis, G., and Giannoudis, P.V. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 39S2, S83, 2008.
35. McKay, W.F., Peckham, S.M., and Badura, J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE-Bone Graft). Int Orthop 31, 729, 2007.
36. Canter, H.I., Vargel, I., Korkusuz, P., Oner, F., Gungorduk, D.B., Cil, B., Karabulut, E., Sargon, M.F., and Erk, Y. Effect of use of slow release of bone morphogenetic protein-2 and transforming growth factor-beta-2 in a chitosan gel matrix on cranial bone graft survival in experimental cranial critical size defect model. Ann Plast Surg 64, 342, 2010.
37. Luca, L., Rougemont, A.-L., Walpoth, B.H., Gurny, R., and Jordan, O. The effects of carrier nature and pH on rhBMP-2-inducedectopic bone formation. JControl Release 147, 38, 2010.
38. Yuan, Q., Lu, H., Tang, S., Liu, K., Pan, Z., Pan, H., Quan, D., Zheng, Q., and Guo, X. Ectopic bone formation in vivo induced by a novel synthetic peptide derived from BMP-2 using porous collagen scaffolds. J Wuhan Univ Technol Mater Sci Ed 22, 701, 2007.
39. Boerckel, J.D., Kolambkar, Y.M., Dupont, K.M., Uhrig, B.A., Phelps, E.A., Stevens, H.Y., García, A.J., and Guldberg, R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32, 5241, 2011.
40. Bessa, P.C., Balmayor, E.R., Azevedo, H.S., Nü rnberger, S., Casal, M., van Griensven, M., Reis, R.L., and Redl, H. Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 4, 349, 2010.
41. Dash, S., Murthy, P.N., Nath, L., and Chowdhury, P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67, 217, 2010.
42. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52, 1145, 1963.
43. Korsmeyer, R.W., Lustig, S.R., and Peppas, N.A. Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling. J Polym Sci Part B Polym Phys 24, 395, 1986.
44. Korsmeyer, R.W., von Meerwall, E., and Peppas, N.A. Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models. J Polym Sci Part B Polym Phys 24, 409, 1986.
45. Niu, X., Feng, Q., Wang, M., Guo, X., and Zheng, Q. Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2. J Microencapsul 26, 297, 2009.
46. Wu, B., Zheng, Q., Guo, X., Wu, Y., Wang, Y., and Cui, F. Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide. Biomed Mater 3, 7, 2008.
47. Hynes, R.O. The extracellular matrix: not just pretty fibrils. Science 326, 1216, 2009.
48. Geiger, M., Li, R.H., and Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55, 1613, 2003.
49. Gelse, K., Pö schl, E., and Aigner, T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 55, 1531, 2003.
50. Di Martino, A., Sittinger, M., and Risbud, M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26, 5983, 2005.
51. Madihally, S.V., and Matthew, H.W.T. Porous chitosan scaffolds for tissue engineering. Biomaterials 20, 1133, 1999.
52. Friess, W., Uludag, H., Foskett, S., Biron, R., and Sargeant, C. Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers. Int J Pharm 185, 51, 1999.
53. Akman, A.C., Tiǧli, R.S., Gümü sxderelioǧlu, M., and Nohutcu, R.M. Bone morphogenetic protein-6-loaded chitosan scaffolds enhance the osteoblastic characteristics of MC3T3-E1 cells. Artif Organs 34, 65, 2009.
54. Celeste, A.J., Iannazzi, J.A., Taylor, R.C., Hewick, R.M., Rosen, V., Wang, E.A., and Wozney, J.M. Identification of transforming growth factor b family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87, 9843, 1990.
55. Ritger, P.L., and Peppas, N.A. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5, 23, 1987.
56. Ritger, P.L., and Peppas, N.A. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5, 37, 1987.
57. Uludag, H., D'Augusta, D., Palmer, R., Timony, G., and Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46, 193, 1999.
58. Uludag, H., D'Augusta, D., Golden, J., Li, J., Timony, G., Riedel, R., and Wozney, J.M. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50, 227, 2000.
59. Kloesch, B., Hoering, B., Dopler, D., Banerjee, A., van Griensven, M., and Redl, H. Synthetic peptides derived from the knuckle epitope of hBMP-2 were evaluated for inducing osteogenic differentiation in vitro and in vivo. Eur Cell Mater 14, 70, 2007.
60. Celeste, A.J., Song, J.J., Cox, K., Rosen, V., and Wozney, J.M. Bone morphogenetic protein-9, a new member of the TGF-b superfamily. J Bone Miner Res 9, S136, 1994.
61. Glynne Andrew, J., Andrew, S.M., Freemont, A.J., and Marsh, D.R. Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65, 462, 1994.
62. Santavirta, S., Konttinnen, Y.T., Nordström, D., Mälekä, A., Sors, T., Hukkanen, M., and Rokkanen, P. Immunologic studies of nonunited fractures. Acta Orthop Scand 63, 579, 1992.
63. Schett, G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011; DOI: 10.1111/j.1365-2362.2011.02545.x.
64. Leblanc, E., Trensz, F., Haroun, S., Drouin, G., Bergeron, E., Penton, C.M., Montanaro, F., Roux, S., Faucheux, N., and Grenier, G. BMP9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res 26, 1166, 2011.